Full-Time

Director – Clinical Operations

Confirmed live in the last 24 hours

Pliant Therapeutics

Pliant Therapeutics

51-200 employees

Develops treatments for fibrotic diseases

Biotechnology
Healthcare

Compensation Overview

$240k - $250kAnnually

Senior

San Bruno, CA, USA

Hybrid position requiring 3 days/week at Pliant in South San Francisco.

Category
Healthcare Administration & Support
Medical, Clinical & Veterinary
Required Skills
Data Analysis
Google Cloud Platform
Requirements
  • Bachelor’s degree required.
  • 12+ years of experience working with CROs to manage large global clinical trials. Rare disease experience is a plus.
  • 3+ years of experience managing direct reports, evidencing strong leadership, team-building, and hands-on management.
  • Comprehensive understanding of ICH and GCP guidelines, as well as applicable regulations and practices.
  • Excellent organizational skills and attention to detail.
  • Effective communication and interpersonal skills.
  • Able to set priorities, juggle multiple demands, and manage changing priorities.
  • Able to think critically and be a proactive problem-solver.
  • Able to work independently while exercising initiative, flexibility, and sound judgment.
  • Comfortable working with different levels of the company including senior level management.
  • Ability to operate in alignment with Pliant’s values and culture.
Responsibilities
  • Accountable for the overall management of assigned clinical programs (across multiple studies), including providing strategic direction to study teams to ensure timely clinical trial execution.
  • Responsible for maintaining inspection-readiness across clinical programs.
  • Assist in development of hiring/resourcing plans and program budgets.
  • Manage multiple direct reports.
  • Mentor and oversee junior team members.
  • Provide oversight of clinical research organizations (CROs) and other key vendors to ensure timely and quality deliverables.
  • Provide a point of escalation for clinical trial execution issues.
  • Lead preparation of vendor requirements and project scope and selection of study vendors.
  • Responsible for clinical vendor selection.
  • Contribute to the establishment of KPIs to measure vendor performance.
  • Implement appropriate systems, standards, and processes to ensure quality at the level of investigative sites, vendors, and data.
  • Oversee the clinical aspects of timely data cleaning, data analysis and the availability of top line results.
  • Oversee set-up and implementation of effective investigator and site monitor training; facilitate operational and therapeutic area training for internal and external study team members.
  • Review study invoices and participate in accrual reviews to track the financial status of the study against budget.
  • Responsible for establishing clinical operations SOPs, Work Instructions, guidelines, standards, and best practices.
  • Drive and implement infrastructure initiatives, process improvements, change management, and ad-hoc business projects.
  • All work must adhere to ICH Good Clinical Practice (GCP) guidelines and comply with company SOPs.

Pliant Therapeutics develops treatments for fibrotic diseases, which cause thickening and scarring of connective tissue, leading to organ dysfunction. Their products work by targeting the biological mechanisms behind fibrosis, particularly through the inhibition of integrins, proteins that help cells stick together and communicate. This focus allows Pliant to create specific and effective therapies for various fibrotic conditions. Unlike many competitors, Pliant emphasizes a deep understanding of fibrosis and integrin biology, which informs their drug development process. The company's goal is to stop the progression of fibrotic diseases and restore normal organ function, ultimately improving the lives of patients affected by these conditions.

Company Stage

IPO

Total Funding

$201.4M

Headquarters

San Francisco, California

Founded

2015

Growth & Insights
Headcount

6 month growth

6%

1 year growth

12%

2 year growth

49%
Simplify Jobs

Simplify's Take

What believers are saying

  • Pliant's accelerated development of bexotegrast for IPF and positive Phase 2a trial results indicate strong potential for successful market entry.
  • The company's participation in high-profile investor events and scientific congresses enhances its visibility and credibility in the biotech community.
  • Recent strategic appointments, including a new Chief Development Officer and Chief Regulatory Officer, bolster Pliant's leadership team and operational capabilities.

What critics are saying

  • The high costs and long timelines associated with drug development pose financial risks, especially if clinical trials do not meet endpoints.
  • The competitive landscape in biopharmaceuticals, particularly in fibrosis treatment, requires Pliant to continuously innovate to maintain its edge.

What makes Pliant Therapeutics unique

  • Pliant Therapeutics focuses specifically on fibrotic diseases, leveraging deep expertise in fibrosis and integrin biology, unlike competitors with broader therapeutic areas.
  • Their targeted approach to integrin inhibition offers a unique mechanism of action that sets them apart from other fibrosis treatments.
  • Pliant's commitment to rigorous clinical trials and data-driven development ensures high standards of efficacy and safety, distinguishing them in the biopharmaceutical market.

Help us improve and share your feedback! Did you find this helpful?